Assessing the survival of transgenic plant DNA in the human gastrointestinal tract

Article Abstract:

The survival of the transgene epsps from genetically modified (GM) Soya in the small intestine of human ileostomists hat is individuals in which the terminal ileum is resected and digesta are diverted from the body via a stoma to a colostomy bag is studied. The results showed a very low level of esps in the intestinal microflora did not increases after consumption of meal containing GM Soya and concluded that gene transfer did not occur during feeding experiment.

Analysis, Causes of, Gastrointestinal system, Ingestion disorders

---

A transformation method for obtaining marker-free plants of a cross-pollinating and vegetatively propagated crop

Article Abstract:

A study is conducted to develop a method that permits the identification of transgenic plants without the use of selectable markers. This method relies on the transformation of tissue explants or cells with a virulent A. tumefaciens strain and selection of transformed cells or shoots after PCR analysis.

Case studies, Pollination

---

Blooming biotech

Article Abstract:

The article discusses the various efforts taken by companies to facilitate recombinant technology and to produce various new genetically modified floriculture products.

Drugs, Biotechnology, Floriculture

Similar abstracts:

• Abstracts: Tests of the Value Line ranking system: some international evidence. A note on the transmission of public information across international stock markets
• Abstracts: Internal marketing: a qualitative study of culture change in the UK banking sector. Marketing challenges in e-banking: standalone or integrated?
• Abstracts: Mapping of conserved RNA secondary structures predicts thousands of functional noncoding RNAs in the human genome
• Abstracts: Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
• Abstracts: Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Enhancement of therapeutic protein in vivo activities through glycoengineering

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.